{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T01:51:56Z","timestamp":1776477116176,"version":"3.51.2"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2012,9,22]],"date-time":"2012-09-22T00:00:00Z","timestamp":1348272000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn J Ophthalmol"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1007\/s10384-012-0186-8","type":"journal-article","created":{"date-parts":[[2012,9,21]],"date-time":"2012-09-21T10:13:15Z","timestamp":1348222395000},"page":"559-563","source":"Crossref","is-referenced-by-count":15,"title":["Three-month evaluation of dorzolamide hydrochloride\/timolol maleate fixed-combination eye drops versus the separate use of both drugs"],"prefix":"10.1007","volume":"56","author":[{"given":"Kenji","family":"Inoue","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minako","family":"Shiokawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michitaka","family":"Sugahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Wakakura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoichi","family":"Soeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Goji","family":"Tomita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,9,22]]},"reference":[{"key":"186_CR1","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0002-9394(98)00272-4","volume":"126","author":"Collaborative Normal-Tension Glaucoma Study Group","year":"1998","unstructured":"Collaborative Normal-Tension Glaucoma Study Group. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Am J Ophthalmol. 1998;126:498\u2013505.","journal-title":"Am J Ophthalmol"},{"key":"186_CR2","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0002-9394(00)00538-9","volume":"130","author":"The AGIS Investigators","year":"2000","unstructured":"The AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol. 2000;130:429\u201340.","journal-title":"Am J Ophthalmol"},{"key":"186_CR3","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/IJG.0b013e3181815421","volume":"18","author":"F Djafari","year":"2009","unstructured":"Djafari F, Lesk MR, Harasymowycz PJ, Desjardins D, Lachaine J. Determinants of adherence to glaucoma medical therapy in a long-term patient population. J Glaucoma. 2009;18:238\u201342.","journal-title":"J Glaucoma"},{"key":"186_CR4","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/S0002-9394(00)00717-0","volume":"130","author":"S Choudhri","year":"2000","unstructured":"Choudhri S, Wand M, Shields MB. A comparison of dorzolamide-timolol combination versus the concomitant drugs. Am J Ophthalmol. 2000;130:832\u20133.","journal-title":"Am J Ophthalmol"},{"key":"186_CR5","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1016\/S0161-6420(98)91045-4","volume":"105","author":"K Strohmaier","year":"1998","unstructured":"Strohmaier K, Snyder E, Dubiner H, Adamsons I, The Dorzolamide-Timolol Study Group. The efficacy and safety of the dorzolamide-timolol combination versus the concomitant administration of its components. Ophthalmology. 1998;105:1936\u201344.","journal-title":"Ophthalmology"},{"key":"186_CR6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1177\/112067210601600113","volume":"16","author":"S Parmaksiz","year":"2006","unstructured":"Parmaksiz S, Y\u00fcksel N, Karabas VL, \u00d6zkan B, Demirci G, Caglar Y. A comparison of travoprost, latanoprost, and the fixed combination of dorzolamide and timolol in patients with pseudoexfolitation glaucoma. Eur J Ophthalmol. 2006;16:73\u201380.","journal-title":"Eur J Ophthalmol"},{"key":"186_CR7","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0161-6420(03)00404-4","volume":"110","author":"AGP Konstas","year":"2003","unstructured":"Konstas AGP, Papapanos P, Tersis I, Houliara D, Stewart WC. Twenty-four-hour diurnal curve comparison of commercially available latanoprost 0.005\u00a0% versus the timolol and dorzolamide fixed combination. Ophthalmology. 2003;110:1357\u201360.","journal-title":"Ophthalmology"},{"key":"186_CR8","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1001\/archopht.121.4.453","volume":"121","author":"N Orzalesi","year":"2003","unstructured":"Orzalesi N, Rossetti L, Bottoli A, Fumagalli E, Fogagnolo P. The effect of latanoprost, bimonidine, and a fixed combination of timolol and dorzolamide on circadian intraocular pressure in patients with glaucoma or ocular hypertension. Arch Ophthalmol. 2003;121:453\u20137.","journal-title":"Arch Ophthalmol"},{"key":"186_CR9","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/j.1600-0420.2004.00358.x","volume":"82","author":"I Janulevicien\u0451","year":"2004","unstructured":"Janulevicien\u0451 I, Harris A, Kagemann L, Siesky B, McCranor L. A comparison of the effects of dorzolamide\/timolol fixed combination versus latanoprost on intraocular pressure and pulsatile ocular blood flow in primary open-angle glaucoma patients. Acta Ophthalmol Scand. 2004;82:730\u20137.","journal-title":"Acta Ophthalmol Scand"},{"key":"186_CR10","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1177\/112067210801800409","volume":"18","author":"J Mulaney","year":"2008","unstructured":"Mulaney J, Sonty S, Ahmad A, Stewart JA, Stewart WC. Comparison of daytime efficacy and safety of dorzolamide\/timolol maleate fixed combination versus latanoprost. Eur J Ophthalmol. 2008;18:556\u201362.","journal-title":"Eur J Ophthalmol"},{"key":"186_CR11","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ophtha.2007.03.007","volume":"115","author":"AGP Konstas","year":"2008","unstructured":"Konstas AGP, Kozobolis VP, Tsironi S, Makridaki I, Efremova R, Stewart WC. Comparison of the 24-hour intraocular pressure-lowering effects of latanoprost and dorzolamide\/timolol fixed combination after 2 and 6\u00a0months of treatment. Ophthalmology. 2008;115:99\u2013103.","journal-title":"Ophthalmology"},{"key":"186_CR12","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1046\/j.1600-0420.2004.0205.x","volume":"82","author":"RD Fechtner","year":"2004","unstructured":"Fechtner RD, Airaksinen PJ, Getson AJ, Lines CR, Adamsons IA. on behalf of the COSOPT versus XALATAN Study Groups. Efficacy and tolerability of the dorzolamide 2\u00a0%\/timolol 0.5\u00a0% combination (COSOPT\u2122) versus latanoprost 0.005\u00a0% (XALATAN\u2122) in the treatment of ocular hypertension or glaucoma: results from two randomized clinical trials. Acta Ophthalmol Scand. 2004;82:42\u20138.","journal-title":"Acta Ophthalmol Scand"},{"key":"186_CR13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/sj.eye.6700257","volume":"17","author":"AGP Konstas","year":"2003","unstructured":"Konstas AGP, Kozobolis VP, Tersis I, Leech J, Stewart WC. The efficacy and safety of the timolol\/dorzolamide fixed combination vs latanoprost in exfoliation glaucoma. Eye. 2003;17:41\u20136.","journal-title":"Eye."},{"key":"186_CR14","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1034\/j.1600-0420.2002.800615.x","volume":"80","author":"FM Honrubia","year":"2002","unstructured":"Honrubia FM, Larsson LI, Spiegel D, The European Latanoprost Study Group. A comparison of the effects on intraocular pressure of latanoprost 0.005\u00a0% and the fixed combination of dorzolamide 2\u00a0% and timolol 0.5\u00a0% in patients with open-angle glaucoma. Acta Ophthalmol Scand. 2002;80:635\u201341.","journal-title":"Acta Ophthalmol Scand"},{"key":"186_CR15","first-page":"495","volume":"115","author":"Y Kitazawa","year":"2011","unstructured":"Kitazawa Y, Araie M, Research Group on MK-0507A. Double-masked, phase III comparative study of the combination ophthalmic solution of the 1\u00a0% dorzolamide hydrochloride\/0.5\u00a0% timolol maleate (MK-0507A) in patients with glaucoma and ocular hypertension. Nippon Ganka Gakkai Zasshi. 2011;115:495\u2013507.","journal-title":"Nippon Ganka Gakkai Zasshi."},{"key":"186_CR16","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/00061198-199400340-00002","volume":"3","author":"Y Kitazawa","year":"1994","unstructured":"Kitazawa Y, Azuma I, Iwata K, Tsukahara S, Shiose Y, Araie M, et al. Dorzolamide, a topical carbonic anhydrase inhibitor: a two-week dose\u2013response study in patients with glaucoma or ocular hypertension. J Glaucoma. 1994;3:275\u20139.","journal-title":"J Glaucoma"},{"key":"186_CR17","doi-asserted-by":"crossref","unstructured":"Mizoguchi T, Ozaki M, Wakiyama H, Ogino N. Additive intraocular pressure-lowering effect of dorzolamide 1\u00a0%\/timolol 0.5\u00a0% fixed combination on prostaglandin monotherapy in patients with normal tension glaucoma. Clin Ophthalmol. 2011;5:1515\u201320.","DOI":"10.2147\/OPTH.S24058"},{"key":"186_CR18","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0021-5155(02)00667-6","volume":"47","author":"K Inoue","year":"2003","unstructured":"Inoue K, Okugawa K, Oshika T, Amano S. Influence of dorzolamide on corneal endothelium. Jpn J Ophthalmol. 2003;47:129\u201333.","journal-title":"Jpn J Ophthalmol"}],"container-title":["Japanese Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-012-0186-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10384-012-0186-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-012-0186-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T03:41:22Z","timestamp":1562211682000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10384-012-0186-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,22]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["186"],"URL":"https:\/\/doi.org\/10.1007\/s10384-012-0186-8","relation":{},"ISSN":["0021-5155","1613-2246"],"issn-type":[{"value":"0021-5155","type":"print"},{"value":"1613-2246","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,22]]}}}